Gray D[au] - Search Results

Year	Number of Results
1946	4
1947	2
1948	4
1949	4
1950	2
1951	2
1952	2
1953	3
1954	8
1955	4
1956	3
1957	4
1958	7
1959	3
1960	8
1961	7
1962	11
1963	6
1964	6
1965	9
1966	2
1967	16
1968	6
1969	8
1970	1
1971	10
1972	9
1973	9
1974	16
1975	13
1976	15
1977	11
1978	19
1979	16
1980	15
1981	17
1982	22
1983	24
1984	41
1985	25
1986	35
1987	33
1988	47
1989	47
1990	35
1991	51
1992	53
1993	52
1994	56
1995	54
1996	46
1997	52
1998	39
1999	55
2000	50
2001	57
2002	47
2003	61
2004	59
2005	64
2006	65
2007	54
2008	63
2009	58
2010	64
2011	56
2012	62
2013	77
2014	101
2015	90
2016	91
2017	91
2018	95
2019	97
2020	104
2021	109
2022	10

1

COVID-19 and the other pandemic: populations made vulnerable by systemic inequity.

Gray DM 2nd, Anyane-Yeboa A, Balzora S, Issaka RB, May FP. Gray DM 2nd, et al. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):520-522. doi: 10.1038/s41575-020-0330-8. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32541960 Free PMC article. Review.

2

Hello World Deep Learning in Medical Imaging.

Lakhani P, Gray DL, Pett CR, Nagy P, Shih G. Lakhani P, et al. Among authors: gray dl. J Digit Imaging. 2018 Jun;31(3):283-289. doi: 10.1007/s10278-018-0079-6. J Digit Imaging. 2018. PMID: 29725961 Free PMC article. Review.

3

Work-Related and Personal Factors Associated With Mental Well-Being During the COVID-19 Response: Survey of Health Care and Other Workers.

Evanoff BA, Strickland JR, Dale AM, Hayibor L, Page E, Duncan JG, Kannampallil T, Gray DL. Evanoff BA, et al. Among authors: gray dl. J Med Internet Res. 2020 Aug 25;22(8):e21366. doi: 10.2196/21366. J Med Internet Res. 2020. PMID: 32763891 Free PMC article.

4

Genomic diagnosis for children with intellectual disability and/or developmental delay.

Bowling KM, Thompson ML, Amaral MD, Finnila CR, Hiatt SM, Engel KL, Cochran JN, Brothers KB, East KM, Gray DE, Kelley WV, Lamb NE, Lose EJ, Rich CA, Simmons S, Whittle JS, Weaver BT, Nesmith AS, Myers RM, Barsh GS, Bebin EM, Cooper GM. Bowling KM, et al. Among authors: gray de. Genome Med. 2017 May 30;9(1):43. doi: 10.1186/s13073-017-0433-1. Genome Med. 2017. PMID: 28554332 Free PMC article.

5

Impact of COVID-19 on colorectal cancer disparities and the way forward.

Balzora S, Issaka RB, Anyane-Yeboa A, Gray DM 2nd, May FP. Balzora S, et al. Among authors: gray dm 2nd. Gastrointest Endosc. 2020 Oct;92(4):946-950. doi: 10.1016/j.gie.2020.06.042. Epub 2020 Jun 20. Gastrointest Endosc. 2020. PMID: 32574570 Free PMC article.

6

Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer.

Whittle JR, Vaillant F, Surgenor E, Policheni AN, Giner G, Capaldo BD, Chen HR, Liu HK, Dekkers JF, Sachs N, Clevers H, Fellowes A, Green T, Xu H, Fox SB, Herold MJ, Smyth GK, Gray DHD, Visvader JE, Lindeman GJ. Whittle JR, et al. Among authors: gray dhd. Clin Cancer Res. 2020 Aug 1;26(15):4120-4134. doi: 10.1158/1078-0432.CCR-19-1872. Epub 2020 Apr 3. Clin Cancer Res. 2020. PMID: 32245900 Free article.

7

Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment.

Best SA, De Souza DP, Kersbergen A, Policheni AN, Dayalan S, Tull D, Rathi V, Gray DH, Ritchie ME, McConville MJ, Sutherland KD. Best SA, et al. Among authors: gray dh. Cell Metab. 2018 Apr 3;27(4):935-943.e4. doi: 10.1016/j.cmet.2018.02.006. Epub 2018 Mar 8. Cell Metab. 2018. PMID: 29526543 Free article.

8

CIS is a potent checkpoint in NK cell-mediated tumor immunity.

Delconte RB, Kolesnik TB, Dagley LF, Rautela J, Shi W, Putz EM, Stannard K, Zhang JG, Teh C, Firth M, Ushiki T, Andoniou CE, Degli-Esposti MA, Sharp PP, Sanvitale CE, Infusini G, Liau NP, Linossi EM, Burns CJ, Carotta S, Gray DH, Seillet C, Hutchinson DS, Belz GT, Webb AI, Alexander WS, Li SS, Bullock AN, Babon JJ, Smyth MJ, Nicholson SE, Huntington ND. Delconte RB, et al. Among authors: gray dh. Nat Immunol. 2016 Jul;17(7):816-24. doi: 10.1038/ni.3470. Epub 2016 May 23. Nat Immunol. 2016. PMID: 27213690

9

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2.

Nguyen LT, Saibil SD, Sotov V, Le MX, Khoja L, Ghazarian D, Bonilla L, Majeed H, Hogg D, Joshua AM, Crump M, Franke N, Spreafico A, Hansen A, Al-Habeeb A, Leong W, Easson A, Reedijk M, Goldstein DP, McCready D, Yasufuku K, Waddell T, Cypel M, Pierre A, Zhang B, Boross-Harmer S, Cipollone J, Nelles M, Scheid E, Fyrsta M, Lo CS, Nie J, Yam JY, Yen PH, Gray D, Motta V, Elford AR, DeLuca S, Wang L, Effendi S, Ellenchery R, Hirano N, Ohashi PS, Butler MO. Nguyen LT, et al. Among authors: gray d. Cancer Immunol Immunother. 2019 May;68(5):773-785. doi: 10.1007/s00262-019-02307-x. Epub 2019 Feb 11. Cancer Immunol Immunother. 2019. PMID: 30747243 Clinical Trial.

10

The worried well.

Gray DP, Dineen M, Sidaway-Lee K. Gray DP, et al. Br J Gen Pract. 2020 Jan 30;70(691):84-85. doi: 10.3399/bjgp20X708017. Print 2020 Feb. Br J Gen Pract. 2020. PMID: 32001474 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results